A groundbreaking discovery has shed light on the potential origins of ankylosing spondylitis (AS), a debilitating autoimmune disease. The research, led by Professor Ranjeny Thomas and her team at The University of Queensland, suggests that the answer may lie in an unexpected place: the gut.
Unraveling the Gut-Joint Connection
AS, which affects 1 in 100 Australians, primarily targets the spine and large joints, leading to a hunched deformity and limited mobility. But here's where it gets controversial: the research team found traces of gut bacteria in the joints of both mice and human patients with AS. This suggests a direct link between the gut and the development of this painful condition.
The study, published in JCI Insight, focused on SKG mice, which are genetically prone to arthritis. By breeding these mice in a microbe-free environment, akin to living in a sterile bubble, the researchers were able to control the presence of gut bacteria. When these mice were introduced to a single gut bacterium and an inflammatory trigger, they developed severe arthritis and inflammation of the entheses, the sites where tendons attach to bones.
However, mice without the arthritis risk gene or those without bacteria remained healthy, highlighting the crucial role of both genetics and the microbiome in the development of AS. Furthermore, mice given a mix of gut bacteria had healthier guts and less severe arthritis, indicating that a balanced gut microbiome may offer protection against autoimmune arthritis.
The Immune System's Role
In genetically susceptible individuals, the gut lining becomes leaky, allowing bacteria to enter the gut tissue. The immune system then activates macrophages, the body's scavengers, to clear these invaders. But in AS patients, these macrophages become overly aggressive. Surprisingly, the research team discovered that these angry macrophages carry bacteria from the gut into the joints, triggering a strong immune reaction driven by IL-17, a key player in the development of arthritis.
This finding was further supported by the presence of bacterial DNA in the synovial tissue of a patient with psoriatic arthritis, suggesting a similar transmission of bacterial DNA from the gut in humans.
Implications and Future Directions
The study's key takeaway is the central role of the interplay between the immune system and gut bacteria in the development of arthritis in genetically at-risk individuals. This opens up new avenues for treating AS and other spondyloarthropathies by targeting gut resilience, altering the gut microbiome, or calming macrophages.
Current treatments for autoimmune arthritis focus on managing pain and stiffness, slowing joint damage, and preventing complications. However, these therapies are not effective for everyone, and around 40% of people eventually discontinue treatment due to side effects or loss of effectiveness. Therefore, there is an urgent need to better understand and find new treatments for AS, which not only presents a medical challenge but also a significant social and economic issue, affecting patients in the prime of their lives.
Prof. Thomas' team is currently running the RA-HEAL trial, comparing structured and self-directed lifestyle improvement programs for recently diagnosed rheumatoid arthritis patients. Additionally, they are developing a promising new approach using liposomes, tiny lipid-based carriers, to deliver disease-related antigens and immune regulators directly to immune cells, aiming to restore immune tolerance in autoimmune diseases like Type 1 Diabetes and rheumatoid arthritis.
This research highlights the importance of gut health in inflammatory arthritis, particularly in individuals experiencing gastrointestinal symptoms. Diet patterns rich in dietary fiber, such as the Mediterranean diet, are associated with a more balanced gut microbiome and have been linked to reduced systemic inflammation and improved immune regulation.
The findings of this study open up exciting possibilities for gut-focused strategies in the management and prevention of AS. By understanding the intricate relationship between the gut, the immune system, and arthritis, we may be able to develop more effective treatments and improve the lives of those affected by this debilitating disease.
